Clinical trial
The Effect of QVAR on Lung Functioning in Chronic Obstructive Pulmonary Disease
NCT00238082 · National Jewish Health, Other · Terminated
Key facts
| NCT number | NCT00238082 |
|---|---|
| Title | The Effect of QVAR on Lung Functioning in Chronic Obstructive Pulmonary Disease |
| Official title | The Effect of HFA-beclomethasone Dipropionate on Static Lung Volumes in COPD |
| Lead sponsor | National Jewish Health, Other |
| Status | Terminated |
| Study type | Interventional |
| Conditions | COPD |
| Intervention type | Drug |
| Interventions | HFA-134A Beclomethasone DIpropionate (QVAR) |
| Enrollment | 20 |
| Start date | Nov 1, 1999 |
| Primary completion | Feb 1, 2005 |
| Completion | Feb 1, 2005 |
| First posted | Oct 13, 2005 |
| Last update posted | Mar 29, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: